This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Begum, N. Articles by Ragolia, L. Search for Related Content PubMed PubMed Citation Articles by Begum, N. Articles by Ragolia, L.

Regulation of Myosin-Bound Protein Phosphatase by Insulin in Vascular Smooth Muscle Cells: Evaluation of the Role of Rho Kinase and Phosphatidylinositol-3-Kinase-Dependent Signaling Pathways

The Diabetes Research Laboratory (N.B., N.D., O.S., J.R., L.R.) Winthrop University Hospital Mineola, New York 11501
School of Medicine (N.B., L.R.) State University of New York @ Stony Brook New York, New York 11794

In this study, we examined the molecular mechanism of myosin-bound protein phosphatase (MBP) regulation by insulin and evaluated the role of MBP in insulin-mediated vasorelaxation. Insulin rapidly stimulated MBP in confluent primary vascular smooth muscle cell (VSMC) cultures. In contrast, VSMCs isolated from diabetic and hypertensive rats exhibited impaired MBP activation by insulin. Insulin-mediated MBP activation was accompanied by a rapid time-dependent reduction in the phosphorylation state of the myosin-bound regulatory subunit (MBS) of MBP. The decrease observed in MBS phosphorylation was due to insulin-induced inhibition of Rho kinase activity. Insulin also prevented a thrombin-mediated increase in Rho kinase activation and abolished the thrombin-induced increase in MBS phosphorylation and MBP inactivation. These data are consistent with the notion that insulin inactivates Rho kinase and decreases MBS phosphorylation to activate MBP in VSMCs. Furthermore, treatment with synthetic inhibitors of phosphatidylinositol-3 kinase (PI3kinase), nitric oxide synthase (NOS), and cyclic guanosine monophosphate (cGMP) all blocked insulin’s effect on MBP activation. We conclude that insulin stimulates MBP via its regulatory subunit, MBS partly by inactivating Rho kinase and stimulating NO/cGMP signaling via PI3-kinase as part of a complex signaling network that controls 20-kDa myosin light chain (MLC₂₀) phosphorylation and VSMC contraction.

This article has been cited by other articles:

				J. H. Lee, T. Palaia, and L. Ragolia Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation Am J Physiol Cell Physiol, February 1, 2009; 296(2): C327 - C338. [Abstract] [Full Text] [PDF]

				R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin Endocr. Rev., August 1, 2007; 28(5): 463 - 491. [Abstract] [Full Text] [PDF]

				J. H. Lee and L. Ragolia AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1355 - C1365. [Abstract] [Full Text] [PDF]

				Z. Xie, W. Su, Z. Guo, H. Pang, S. R. Post, and M. C. Gong Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells Cardiovasc Res, February 1, 2006; 69(2): 491 - 501. [Abstract] [Full Text] [PDF]

				H. Pang, Z. Guo, W. Su, Z. Xie, M. Eto, and M. C. Gong RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells Am J Physiol Cell Physiol, August 1, 2005; 289(2): C352 - C360. [Abstract] [Full Text] [PDF]

				L. Ragolia, T. Palaia, T. B. Koutrouby, and J. K. Maesaka Inhibition of cell cycle progression and migration of vascular smooth muscle cells by prostaglandin D2 synthase: resistance in diabetic Goto-Kakizaki rats Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1273 - C1281. [Abstract] [Full Text] [PDF]

				A. Jacob, A. Smolenski, S. M. Lohmann, and N. Begum MKP-1 expression and stabilization and cGK I{alpha} prevent diabetes- associated abnormalities in VSMC migration Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1077 - C1086. [Abstract] [Full Text] [PDF]

				E. A. Wehrwein, C. A. Northcott, R. D. Loberg, and S. W. Watts Rho/Rho Kinase and Phosphoinositide 3-Kinase Are Parallel Pathways in the Development of Spontaneous Arterial Tone in Deoxycorticosterone Acetate-Salt Hypertension J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1011 - 1019. [Abstract] [Full Text] [PDF]

				J. R. Sowers Insulin resistance and hypertension Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1597 - H1602. [Abstract] [Full Text] [PDF]

				X. Su, E. M. Smolock, K. N. Marcel, and R. S. Moreland Phosphatidylinositol 3-kinase modulates vascular smooth muscle contraction by calcium and myosin light chain phosphorylation-independent and -dependent pathways Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H657 - H666. [Abstract] [Full Text] [PDF]

				N. V. Bogatcheva, A. D. Verin, P. Wang, A. A. Birukova, K. G. Birukov, T. Mirzopoyazova, D. M. Adyshev, E. T. Chiang, M. T. Crow, and J. G. N. Garcia Phorbol esters increase MLC phosphorylation and actin remodeling in bovine lung endothelium without increased contraction Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L415 - L426. [Abstract] [Full Text] [PDF]

				L. Ragolia, T. Palaia, E. Paric, and J. K. Maesaka Prostaglandin D2 Synthase Inhibits the Exaggerated Growth Phenotype of Spontaneously Hypertensive Rat Vascular Smooth Muscle Cells J. Biol. Chem., June 6, 2003; 278(24): 22175 - 22181. [Abstract] [Full Text] [PDF]

				H. Teoh, M. Zacour, A. D. Wener, L. Gunaratnam, and M. E. Ward Increased myofibrillar protein phosphatase-1 activity impairs rat aortic smooth muscle activation after hypoxia Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1182 - H1189. [Abstract] [Full Text] [PDF]

				K. Nobe, Y. Sakai, H. Nobe, J. Takashima, R. J. Paul, and K. Momose Enhancement Effect under High-Glucose Conditions on U46619-Induced Spontaneous Phasic Contraction in Mouse Portal Vein J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1129 - 1142. [Abstract] [Full Text] [PDF]

				C. Yan, D. Kim, T. Aizawa, and B. C. Berk Functional Interplay Between Angiotensin II and Nitric Oxide: Cyclic GMP as a Key Mediator Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 26 - 36. [Abstract] [Full Text] [PDF]

				D. K. Rohra, T. Yamakuni, K.-I. Furukawa, N. Ishii, T. Shinkawa, T. Isobe, and Y. Ohizumi Stimulated Tyrosine Phosphorylation of Phosphatidylinositol 3-Kinase Causes Acidic pH-Induced Contraction in Spontaneously Hypertensive Rat Aorta J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1255 - 1264. [Abstract] [Full Text] [PDF]

				A. Jacob, J. D. Molkentin, A. Smolenski, S. M. Lohmann, and N. Begum Insulin inhibits PDGF-directed VSMC migration via NO/ cGMP increase of MKP-1 and its inactivation of MAPKs Am J Physiol Cell Physiol, September 1, 2002; 283(3): C704 - C713. [Abstract] [Full Text] [PDF]

				N. Begum, O. A. Sandu, and N. Duddy Negative Regulation of Rho Signaling by Insulin and Its Impact on Actin Cytoskeleton Organization in Vascular Smooth Muscle Cells: Role of Nitric Oxide and Cyclic Guanosine Monophosphate Signaling Pathways Diabetes, July 1, 2002; 51(7): 2256 - 2263. [Abstract] [Full Text] [PDF]

				N. Begum, O. A. Sandu, M. Ito, S. M. Lohmann, and A. Smolenski Active Rho Kinase (ROK-alpha ) Associates with Insulin Receptor Substrate-1 and Inhibits Insulin Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., February 15, 2002; 277(8): 6214 - 6222. [Abstract] [Full Text] [PDF]

				O. A. Sandu, M. Ito, and N. Begum Signal Transduction in Smooth Muscle: Selected Contribution: Insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle J Appl Physiol, September 1, 2001; 91(3): 1475 - 1482. [Abstract] [Full Text] [PDF]